(HealthDay News) — The U.S. Food and Drug Administration has approved Penmenvy (Meningococcal Groups A, B, C, W, and Y Vaccine) for active immunization against invasive meningococcal disease (IMD), ...
Shingrix generated sales of £760 million in the quarter, up 51% and around $75 million ahead of expectations, with meningococcal ... our new RSV vaccine," said GSK's chief executive Emma Walmsley ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback